Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.61−0.05 (-1.88%)
Close on Nov 17, 2026Market cap $23.53MP/E –Yield –
Nasus Pharma gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Nasus Pharma
Nasus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?